Fluticasone Propionate Articles

A&H cuts Flixotide price in UK

6 July 1999

Cutivate cleared for children under two

24 June 1999

GW files first dossiers for Flixotide in COPD

10 May 1999

GW gets FDA extension in Relenza review

8 April 1999

Seretide launched in UK and shows promise in comparative trials

3 March 1999

AstraZeneca's Effect On Rest Of Pharma Sector

17 December 1998

GW's Flixotide In ISOLDE Trial

22 September 1998

First Appro For GW's Seretide In Sweden

9 September 1998

GW Files For Approval Of Seretide Combo

30 April 1998

Forest Files Two New Applications For Aerobid

16 February 1998

High Hopes For New Products At Rhone-Poulenc

5 February 1998

Drug Delivery Sales "To Grow 15% A Year To 2005"

4 February 1998

Lehman Upgrades Euro Pharmaceutical Sector

12 January 1998

News In Brief

7 November 1997

Astra's Pulmicort Turbuhaler Cleared In USA

26 June 1997

Upbeat UK Companies At Goldman Sachs Conference

17 June 1997

Forest Labs At Risk In Fight To Return To Profits?

9 June 1997

Investors Impressed With Glaxo Wellcome Pipeline

12 May 1997

Glaxo Wellcome 1996 Product Performance

17 March 1997

Glaxo Wellcome Breaches IFPMA Marketing Code

3 February 1997

Astra Gets US "Approvable" Letter For Pulmicort Turbo

1 July 1996

GW's Flovent Approved In USA

8 April 1996

USA Lags Foreign Approvals, PhRMA Demonstrates

16 October 1995

European Stock Comment

9 October 1995

GW's Flovent Nears US Approval

9 October 1995

Allen & Hanbury's Accuhaler

22 May 1995

Glaxo Interim Profits Up 10% On 2% Sales Rise

13 February 1995

Glaxo Receives Approval For Flonase

31 October 1994

Glaxo's Pipeline Update As Expected

19 September 1994

Nippon Glaxo Launch Of Flunase

19 September 1994

Flunase Approved In Japan

18 July 1994

FLUTICASONE CLAIMS QUESTIONED

13 June 1994

GLAXO LAUNCH

16 May 1994

D&TB: NEGATIVE REVIEW OF FLIXOTIDE

9 May 1994

UK INDUSTRY REPORT ON "BRIBERY" CHARGES

21 March 1994

ROUND-UP OF 1993'S NEW CHEMICAL ENTITIES

31 January 1994

GLAXO REAFFIRMS COMMITMENT TO R&D

6 December 1993

FIRST ASTHMA LAUNCH FOR FLIXOTIDE

15 March 1993

ANALYST TIPS GLAXO FOR CONTINUED SUCCESS

15 February 1993

Jan Lundberg tells the Marketletter how AstraZeneca is turning around its pipeline